|
[1]
|
Chen, L., Liu, R., Liu, Z.P., et al. (2012) Detecting Early-Warning Signals for Sudden Deterioration of Complex Diseases by Dynamical Network Biomarkers. Scientific Reports, 2, 342. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Strogatz, S.H. (2000) Nonlinear Dynamics and Chaos: With Applications to Physics, Biology, Chemistry, and Engineering. Perseus Books Publishing, New York.
|
|
[3]
|
Liu, X., Xiao, C., Rui, L., et al. (2017) Quantifying Critical States of Complex Diseases Using Single-Samples Dynamic Network Biomarkers. PLoS Computational Biology, 13, e1005633.
[Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Louro, R., Nakaya, H.I., Amaral, P.P., et al. (2007) Androgen Responsive Intronic Non-Coding RNAs. BMC Biology, 5, 4. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lempiäinen, H., Couttet, P., Bolognani, F., et al. (2013) Identification of Dlk1-Dio3 Imprinted Gene Cluster Noncoding RNAs as Novel Candidate Biomarkers for Liver Tumor Promotion. Toxicological Sciences: An Official Journal of the Society of Toxicology, 131, 375. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Nesbit, C.E., Tersak, J.M. and Prochownik, E.V. (1999) MYC Oncogenes and Human Neoplastic Disease. Oncogene, 18, 3004-3016. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Jenkins, R.B., Qian, J., Lieber, M.M., et al. (1997) Detection of C-MYC Oncogene Amplification and Chromosomal Anomalies in Metastatic Prostatic Carcinoma by Fluorescence in Situ Hybridization. Cancer Research, 57, 524-531.
|
|
[8]
|
Sun, C., Dobi, A., Mohamed, A., et al. (2008) TMPRSS2-ERG Fusion, a Common Genomic Alteration in Prostate Cancer Activates C-MYC and Abrogates Prostate Epithelial Differentiation. Oncogene, 27, 5348-5353.
[Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Chi, S.G., White, R.W.D., Meyers, F.J., et al. (1994) p53 in Prostate Cancer: Frequent Expressed Transition Mutations. Journal of the National Cancer Institute, 86, 926-933. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Battaglia, S., Maguire, O., Thorne, J.L., et al. (2010) Elevated NCOR1 Disrupts PPARα/γ Signaling in Prostate Cancer and Forms a Targetable Epigenetic Lesion. Carcinogenesis, 31, 1650. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lai, K.K., Shang, S., Lohia, N., et al. (2011) Extracellular Matrix Dynamics in Hepatocarcinogenesis: A Comparative Proteomics Study of PDGFC Transgenic and Pten Null Mouse Models. PLoS Genetics, 7, e1002147.
[Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Clegg, N., Ferguson, C., True, L.D., et al. (2003) Molecular Characterization of Prostatic Small-Cell Neuroendocrine Carcinoma. Prostate, 55, 55-64. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Tesori, V., Piscaglia, A.C., Samengo, D., et al. (2015) The Multikinase Inhibitor Sorafenib Enhances Glycolysis and Synergizes with Glycolysis Blockade for Cancer Cell Killing. Scientific Reports, 5, 9149.
[Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Judson, R.S., Houck, K.A., Kavlock, R.J., et al. (2010) In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project. Environmental Health Perspectives, 118, 485.
[Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Camarero, N., Mascaró, C., Mayordomo, C., et al. (2006) Ketogenic HMGCS2 Is a C-MYC Target Gene Expressed in Differentiated Cells of Human Colonic Epithelium and Down-Regulated in Colon Cancer. Molecular Cancer Research, 4, 645. [Google Scholar] [CrossRef]
|
|
[16]
|
Eferl, R., Ricci, R., Kenner, L., et al. (2003) Liver Tumor Development. C-JUN Antagonizes the Proapoptotic Activity of p53. Cell, 112, 181-192. [Google Scholar] [CrossRef]
|